Van Hulzen Asset Management, LLC Moderna, Inc. Transaction History

Van Hulzen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $241,968 - $429,321	2,044 New	2,044 $367,000
Q2 2022 Aug 04, 2022	SELL	$117.13 - $176.59 $145,709 - $219,677	-1,244 Closed	0 $0
Q1 2022 May 20, 2022	SELL	$126.46 - $235.05 $483,077 - $897,891	-3,820 Reduced 75.43%	1,244 $214,000
Q4 2021 Feb 04, 2022	BUY	$225.82 - $368.51 $834,404 - $1.36 Million	3,695 Added 269.91%	5,064 $1.29 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $303,781 - $663,239	1,369 New	1,369 $527,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.